Emily Mason-Osann
Associate Principal Scientist, In Vivo Bioscience AstraZeneca
Seminars
Monday 23rd February 2026
Evaluating Mechanisms of ADC Drug Resistance & Strategies of Rational & Orthogonal Combinations to Improve Outcomes
11:30 am
- Understanding the role of antigen and payload-mediated resistance mechanisms
- Laying out considerations of how cellular heterogeneity can contribute to ADC resistance
- Exploring examples of how mechanistic and orthogonal combinations can be applied towards improving ADC activity
